Abstract
RNA is rapidly emerging as a versatile building block for nanoparticle assembly due to its simplicity in base pairing, while exhibiting diversity in function such as enzymatic activity similar to some proteins. Recent advances in RNA nanotechnology have generated significant interests in applying RNA nanoparticles for various applications in nanotechnology and nanomedicine. In particular, assessing the effect of size and shape on cell entry and intracellular trafficking as well as in vivo biodistribution of nanoparticles is challenging due to the lack of nanoparticles rich in structure while varying in size and shape. RNA nanotechnology exemplified by the packaging RNA (pRNA) of bacteriophage phi29 DNA packaging motor has provided a different prospect in nanoparticle designs. Of note, there is a robust three-way junction (3WJ) motif in pRNA which can serve as an adaptable scaffold to construct thermodynamically stable 2D planar and 3D globular RNA architectures with tunable shapes and sizes, and harboring various targeting, therapeutic, and imaging modules. This chapter focuses on the methods for constructing pRNA-3WJ based nanoparticles with controllable sizes and shapes, and assessment of their biodistribution profiles in cancer mouse models after systemic injection and ocular mouse models following subconjunctival injection.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Puri A, Loomis K, Smith B et al (2009) Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst 26:523–580
Weijun L, Francis CS (2007) Lipid-based nanoparticles for nucleic acid delivery. Pharm Res 24:438–449
Vo-Dinh T (2005) Protein nanotechnology: the new frontier in biosciences. Methods Mol Biol 300:1–13
Zhang F, Nangreave J, Liu Y et al (2014) Structural DNA nanotechnology: state of the art and future perspective. J Am Chem Soc 136:11198–11211
Guo P (2010) The emerging field of RNA nanotechnology. Nat Nanotechnol 5:833–842
Seeman NC (1982) Nucleic acid junctions and lattices. J Theor Biol 99:237–247
Seeman NC (2010) Nanomaterials based on DNA. Annu Rev Biochem 79:65–87
Lin C, Liu Y, Yan H (2009) Designer DNA nanoarchitectures. Biochemistry 48:1663–1674
Sugimoto N, Nakano S, Katoh M et al (1995) Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes. Biochemistry 34:11211–11216
Searle MS, Williams DH (1993) On the stability of nucleic acid structures in solution: enthalpy-entropy compensations, internal rotations and reversibility. Nucleic Acids Res 21:2051–2056
Lemieux S, Major F (2002) RNA canonical and non-canonical base pairing types: a recognition method and complete repertoire. Nucleic Acids Res 30:4250–4263
Leontis NB, Westhof E (2001) Geometric nomenclature and classification of RNA base pairs. RNA 7:499–512
Scott WG (2007) Ribozymes. Curr Opin Struct Biol 17:280–286
Breaker RR (2012) Riboswitches and the RNA world. Cold Spring Harb Perspect Biol 4:a003566
Ryther RC, Flynt AS, Phillips JA III et al (2005) siRNA therapeutics: big potential from small RNAs. Gene Ther 12:5–11
Ha M, Kim VN (2014) Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15:509–524
Zhou J, Bobbin ML, Burnett JC et al (2012) Current progress of RNA aptamer-based therapeutics. Front Genet 3:234
Shu Y, Pi F, Sharma A et al (2014) Stable RNA nanoparticles as potential new generation drugs for cancer therapy. Adv Drug Deliv Rev 66C:74–89
Guo P, Haque F, Hallahan B et al (2012) Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology. Nucleic Acid Ther 22:226–245
Li H, Lee T, Dziubla T et al (2015) RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications. Nano Today 10:631–655
Guo P, Erickson S, Anderson D (1987) A small viral RNA is required for in vitro packaging of bacteriophage phi29 DNA. Science 236:690–694
Guo P, Zhang C, Chen C et al (1998) Inter-RNA interaction of phage phi29 pRNA to form a hexameric complex for viral DNA transportation. Mol Cell 2:149–155
Shu D, Shu Y, Haque F et al (2011) Thermodynamically stable RNA three-way junctions for constructing multifuntional nanoparticles for delivery of therapeutics. Nat Nanotechnol 6:658–667
Zhang H, Endrizzi JA, Shu Y et al (2013) Crystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the Phi29 hexameric motor pRNA. RNA 19:1226–1237
Binzel DW, Khisamutdinov EF, Guo P (2014) Entropy-driven one-step formation of Phi29 pRNA 3WJ from three RNA fragments. Biochemistry 53:2221–2231
Binzel D, Khisamutdinov EF, Vieweger M et al (2016) Mechanism of three-component collision to produce ultra-stable pRNA three-way junction of Phi29 DNA-packaging motor by kinetic assessment. RNA 22:1710–1718
Haque F, Shu D, Shu Y et al (2012) Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers. Nano Today 7:245–257
Shu Y, Haque F, Shu D et al (2013) Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs. RNA 19:766–777
Liu J, Guo S, Cinier M et al (2011) Fabrication of stable and RNase-resistant RNA nanoparticles active in gearing the nanomotors for viral DNA packaging. ACS Nano 5:237–246
Shu D, Khisamutdinov E, Zhang L et al (2013) Programmable folding of fusion RNA complex driven by the 3WJ motif of phi29 motor pRNA. Nucleic Acids Res 42:e10
Abdelmawla S, Guo S, Zhang L et al (2011) Pharmacological characterization of chemically synthesized monomeric pRNA nanoparticles for systemic delivery. Mol Ther 19:1312–1322
Cui D, Zhang C, Liu B et al (2015) Regression of gastric cancer by systemic injection of RNA nanoparticles carrying both ligand and siRNA. Sci Rep 5:10726
Shu D, Li H, Shu Y et al (2015) Systemic delivery of anti-miRNA for suppression of triple negative breast cancer utilizing RNA nanotechnology. ACS Nano 9:9731–9740
Binzel D, Shu Y, Li H et al (2016) Specific delivery of MiRNA for high efficient inhibition of prostate cancer by RNA nanotechnology. Mol Ther 24(7):1267–1277
Rychahou P, Haque F, Shu Y et al (2015) Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration. ACS Nano 9:1108–1116
Lee TJ, Haque F, Shu D et al (2015) RNA nanoparticles as a vector for targeted siRNA delivery into glioblastoma mouse model. Oncotarget 6:14766–14776
Li H, Zhang K, Pi F et al (2016) Controllable self-assembly of RNA tetrahedrons with precise shape and size for cancer targeting. Adv Mater 34:7501–7507
Khisamutdinov E, Li H, Jasinski D et al (2014) Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square, and pentagon nanovehicles. Nucleic Acids Res 42:9996–10004
Sharma A, Haque F, Pi F et al (2015) Controllable self-assembly of RNA dendrimers. Nanomed Nanotechnol Biol Med 12:835–844
Khisamutdinov EF, Jasinski DL, Li H et al (2016) Fabrication of RNA 3D nanoprism for loading and protection of small RNAs and model drugs. Adv Mater 28(45):10079–10087
Feng L, Li SK, Liu H et al (2014) Ocular delivery of pRNA nanoparticles: distribution and clearance after subconjunctival injection. Pharm Res 31:1046–1058
Shu Y, Shu D, Haque F et al (2013) Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells. Nat Protoc 8:1635–1659
Rychahou P, Shu Y, Haque F et al (2015) Methods and assays for specific targeting and delivery of RNA nanoparticles to cancer metastases. Methods Mol Biol 1297:121–135
Lee TJ, Haque F, Vieweger M et al (2015) Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor. Methods Mol Biol 1297:137–152
Jasinski D, Schwartz C, Haque F et al (2015) Large scale purification of RNA nanoparticles by preparative ultracentrifugation. Methods Mol Biol 1297:67–82
Zhang H, Pi F, Shu D et al (2015) Using RNA nanoparticles with thermostable motifs and fluorogenic modules for real-time detection of RNA folding and turnover in prokaryotic and eukaryotic cells. Methods Mol Biol 1297:95–111
Khisamutdinov EF, Bui MN, Jasinski D et al (2015) Simple method for constructing RNA triangle, square, Pentagon by tuning interior RNA 3WJ angle from 60 degrees to 90 degrees or 108 degrees. Methods Mol Biol 1316:181–193
Jasinski D, Khisamutdinov EF, Lyubchenko YL et al (2014) Physicochemically tunable poly-functionalized RNA square architecture with fluorogenic and ribozymatic properties. ACS Nano 8:7620–7629
Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406–3415
Acknowledgments
The research was supported by NIH grants R01EB019036, U01CA151648 and U01CA207946. P.G.’s Sylvan G. Frank Endowed Chair position in Pharmaceutics and Drug Delivery is funded by the CM Chen Foundation. P.G. is the founder of P&Z Biological Technology and a consultant of Oxford Nanopore and Nanobiodelivery Pharmaceutical Co. Ltd.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Haque, F., Xu, C., Jasinski, D.L., Li, H., Guo, P. (2017). Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice. In: Bindewald, E., Shapiro, B. (eds) RNA Nanostructures . Methods in Molecular Biology, vol 1632. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7138-1_23
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7138-1_23
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7137-4
Online ISBN: 978-1-4939-7138-1
eBook Packages: Springer Protocols